Boldo, P, Cárcel-Márquez, J, Carol, LL, Muiño, E, Fabrega, CG, Cullell, N, Lledós, M, Martín-Campos, J, Villatoro-González, P, Mariné, L, Belbin, O, Iglesias-Rey, R, Campos-Perez, F, Mosqueira, A, Freijo, MDM, Arenillas, JF, Obach, V, Alvarez-Sabín, J, Molina, C, Ribo, M, Jiménez-Conde, J, Muñoz-Narbona, L, Lopez-Cancio, E, Millán, M, Diaz-Navarro, R, Vives-Bauza, C, Serrano-Heras, G, Segura, T, Ibañez, L, Heitsch, L, Delgado, P, Dhar, R, Krupinski, J, Prats-Sanchez, L, Camps-Renom, P, Guasch, M, Ezcurra, G, Blay, N, Sumoy, L, De Cid, R, Montaner, J, Castillo, J, Sobrino, T, Cruchaga, C, Lee, JM, Martí-Fàbregas, J, Fernández-Cadenas, I. SEX-STRATIFIED GENETIC RISK OF STROKE: FINDINGS FROM AN X-CHROMOSOME-WIDE ASSOCIATION STUDY. International Journal of Stroke. 2025; 20DOI:. PMID:. IF:8.700(Q1/1D).

Gomez-Choco, M, Font, MA, Avellaneda-Gomez, C, Boned, S, Mengual, JJ, Garcia-Sánchez, SM, Rosa, I, Millán, M, Cardona, P, Molina, C, Silva, Y, Purroy, F, Camps-Renom, P, Rodríguez-Campello, A, Ustrell, X, Krupinski, J, Cánovas, D, Palomeras, E, Zaragoza-Brunet, J, Cocho, D, Mas, N, Jimenez, FX, Salvat-Plana, M, Abilleira, S. IMPACT OF EARLY NEUROLOGICAL DETERIORATION BEFORE ENDOVASCULAR TREATMENT ON FUNCTIONAL OUTCOMES IN MILD STROKE PATIENTS. International Journal of Stroke. 2025; 20(2_SUPPL)DOI:. PMID:. IF:8.700(Q1/1D).

Yakushiji, Y, Best, J, Ikeda, S, Ambler, G, Nishihara, M, Wilson, D, Tanaka, J, Nash, P, Lee, KJ, Koga, M, Chabriat, H, Lau, GKK, Prats-Sanchez, L, Ay, H, Veltkam, R, Mok, V, Heo, JH, Engelter, S, Peters, N, Lemmens, R, Gattringer, T, Orken, DN, Bornstein, N, Smith, E, Kwa, V, Jung, S, Phan, T, Fluri, F, Calvet, D, Chappell, F, Makin, S, Soo, Y, Kelly, P, Van der Lugt, A, Simister, R, De Leeuw, FE, Kandiah, N, Bordet, R, Köhler, S, Van Oostenburgge, R, Lou, M, Chen, C, Staals, J, Wardlaw, J, Srikanth, V, Thijs, V, Imaizumi, T, Marti-Fabregas, J, Bae, HJ, Toyoda, K, Hara, H, Werring, D. DISTRIBUTION OF CEREBRAL MICROBLEED IN THE EAST AND WEST IN PATIENTS ISCHEMIC STROKE AND TIA: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM COHORT STUDIES. International Journal of Stroke. 2025; 20DOI:. PMID:. IF:8.700(Q1/1D).

Prats-Sanchez, L, Lledós, M, Ezcurra, G, Martí-Fàbregas, J, Lambea-Gil, A, Guasch, M, Martinez-Domeño, A, Fernandez-Vidal, JM, Ramos-Pachón, A, Villatoro-Gónzalez, P, Puig, N, Simon, AA, Fernández-Cadenas, I, Camps-Renom, P. FROM GUT TO BRAIN: THE MICROBIOME'S INFLUENCE ON INFECTIONS AFTER INTRACEREBRAL HEMORRHAGE. International Journal of Stroke. 2025; 20DOI:. PMID:. IF:8.700(Q1/1D).

Romeu, MD, Guasch, M, Ezcurra, G, Lambea-Gil, A, Ramos-Pachón, A, Martínez-Domeño, A, Prats-Sanchez, L, Fernandez-Vidal, JM, Toscano-Prat, C, Martí-Fàbregas, J, Martínez-González, JP, Fernández-Cadenas, I, Cardona, P, Rodriguez-Villatoro, N, Rodríguez-Vázquez, A, Gomis, M, Xuclà-Ferrarons, T, Rodrìguez-Campello, A, Cánovas, D, Seró, L, Purroy, F, Salvat-Plana, M, Abilleira, S, Camps-Renom, P. EXTERNAL VALIDATION OF TWO PREDICTIVE SCORES FOR HEMORRHAGIC TRANSFORMATION FOLLOWING ENDOVASCULAR THROMBECTOMY IN A POPULATIONBASED STUDY. International Journal of Stroke. 2025; 20DOI:. PMID:. IF:8.700(Q1/1D).

Eggers, C, Allen, J, Lin, J, Stettner, M, Guptill, J, Istas, G, De Roeck, A, Kuwabara, S, Lauria, G, Querol, L, Suresh, N, Karam, C, Skripuletz, T, Rinaldi, S, Echaniz-Laguna, A, Hewamadduma, C, Van Hoorick, B, Yamasaki, R, van Doorn, P, Lewis, R. ADHERE plus trial interim analysis: long-term safety and efficacy of efgartigimod in chronic inflammatory demyelinating polyneuropathy (CIDP). NEUROMUSCULAR DISORDERS. 2025; 53DOI:10.1016/j.nmd.2025.105858. PMID:. IF:2.800(Q2/5D).

Toscano, A, Bratkovic, D, Claeys, K, Díaz-Manera, J, Mozaffar, T, Roberts, M, Schoser, B, van der Ploeg, A, Jain, V, Holdbrook, F, Moore, P, O'Brien-Prince, K, Kishnani, P. 208-week efficacy and safety of cipaglucosidase alfa plus miglustat in patients with late-onset Pompe disease treated from PROPEL baseline: muscle function and biomarkers. NEUROMUSCULAR DISORDERS. 2025; 53DOI:10.1016/j.nmd.2025.105857. PMID:. IF:2.800(Q2/5D).

Kleefeld, F, Vigo, EG, Gamboa, JT, Funke, A, Roos, A, Mensch, A, Gehrig, J, Ruck, T, Mossakowski, A, Llanso, L, Bortolani, S, Torchia, E, Casal-Dominguez, M, Pinal-Fernandez, I, Mammen, A, Tasca, G, Preusse, C, Stenzel, W. Brachio-cervical inflammatory myopathy: evidence for a distinct form of inflammatory muscle disease. NEUROMUSCULAR DISORDERS. 2025; 53DOI:10.1016/j.nmd.2025.105458. PMID:. IF:2.800(Q2/5D).